StockCIK 1237831

GLOBUS MEDICAL INC (GMED): Insider Trades and Fund Holdings

In the past 12 months, GLOBUS MEDICAL INC insiders reported 0 open-market purchases worth $0 and 2 sales worth $4.41M; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$4.41MSold by insiders, 12 months

3Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 16, 2026.

Recent GMED insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 16	Sep 15	James R. TobinDirector	Director	▼ SELL	30,000	74.58	$2.24M	All sold	Form 4 ↗
Aug 19	Aug 18	Stephen T. ZarrilliDirector	Director	▼ SELL	25,000	87.04	$2.18M	All sold	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
James R. Tobin	Director	0	$0	1	$2.24M	Sep 16, 2026
Stephen T. Zarrilli	Director	0	$0	1	$2.18M	Aug 19, 2026

Tracked funds that report GMED

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Bridgewater Associates	Q2 2026	351,974	$27.8M	0.11%	▲ +6.5%
Renaissance Technologies	Q2 2026	196,918	$15.6M	0.02%	▲ New
Ruane, Cunniff & Goldfarb	Q2 2026	6,008	$475K	0.01%	No change

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →